HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.

AbstractOBJECTIVE:
Obesity is characterized by low basal levels of growth hormone (GH) and impeded GH release. However, the main problem arises in the diagnosis of GH deficiency in adults, as all accepted cut-offs in the diagnostic tests of GH reserve are no longer valid in obese subjects. In this work, the role of obesity in the GH response elicited by the GHRH + GHRP-6 test was assessed in a large population of obese and nonobese subjects.
PATIENTS:
GHRH + GHRP-6-induced GH peaks were evaluated in 542 subjects. One hundred and five were healthy obese, 50 were morbid obese, and 261 were nonobese (both normal weight and overweight). One hundred and seventy-six GH-deficient patients (obese and nonobese) were also studied.
RESULTS:
A regression analysis of the 366 subjects with normal pituitary function indicated that adiposity had a negative effect on the elicited GH peak (r = -0.503, P < 0.0001). A receiver operating characteristic (ROC) curve analysis showed that in subjects with a BMI < or =35, the currently accepted cut-offs of the GHRH + GHRP-6 test (GH peaks > or =20 microg/l: normal secretion; GH peaks < or =10 microg/l: GH deficiency), were fully operative. However, in subjects with a BMI > 35, normality was indicated by GH peaks > or =15 microg/l and GH deficiency by peaks < or =5 microg/l (1 microg/l = 2.6 mU/l).
CONCLUSIONS:
This study confirms: (a) that the combined provocative test is adequate to separate normal and GH-deficient subjects; (b) the negative effect of obesity on GH secretion; (c) that obesity accounts for 25% of the reduction of GH release; and (d) that present cut-off values are applicable to normal weight, overweight and grade I obesity subjects, whereas in obese subjects with a BMI exceeding 35, all the normative limits of the GHRH-GHRP +6 test must be reduced by 5 microg/l.
AuthorsFahrettin Kelestimur, Vera Popovic, Alfonso Leal, P Sytze Van Dam, Elena Torres, Luisa F Perez Mendez, Yona Greenman, Hans P F Koppeschaar, Carlos Dieguez, Felipe F Casanueva
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 64 Issue 6 Pg. 667-71 (Jun 2006) ISSN: 0300-0664 [Print] England
PMID16712669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligopeptides
  • growth hormone releasing hexapeptide
  • Growth Hormone
  • Growth Hormone-Releasing Hormone
Topics
  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • Female
  • Growth Hormone (blood, deficiency, secretion)
  • Growth Hormone-Releasing Hormone
  • Humans
  • Male
  • Middle Aged
  • Obesity (blood, physiopathology)
  • Obesity, Morbid (blood, physiopathology)
  • Oligopeptides
  • Predictive Value of Tests
  • ROC Curve
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: